Genital Chlamydia trachomatis infection is a significant public health burden; Professor of Pediatrics and Microbiology and ...

Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...

MacMaster, Ph.D., associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment ...

so Scharffenberger set out to create an anti-idiotype antibody with the potential to become an RSV vaccine. The first step to ...

To compare EI with needle injection through these conventional routes, we used a formalin-inactivated Aichi/68 influenza virus to immunize BALB/c mice (n = 8 per group). For EI, the vaccine was ...

Tonix Pharma ( (TNXP)) has provided an update. Tonix Pharmaceuticals has unveiled promising data for its TNX-801 vaccine, showing it is less virulent in immune-compromised mice compared to ...

Most people don’t enjoy getting shots for treatments or vaccines. So, researchers are working to create ... when nebulized ...

Current cancer vaccine approaches usually focus on therapeutic vaccines since autoimmune complications are a concern in the preventive setting. Now, reporting in Nature Medicine, Jaini and ...

The vaccine, which blocks a protein believed ... more than doubled compared to when no measures were taken. In the cases of vaccinated mice, the brain’s areas atrophied by dementia were only ...

Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

Vaccinated mice even survived a second infection six months later. A version of the vaccine that also targeted its spores appeared to prime mice and nonhuman primates to fight off C. diff infections.